# TOPGEAR (NCT01924819)

> Trial of Preoperative Therapy for Gastric and Esophagogastric Junction Adenocarcinoma

No report yet. It can be ordered.

## Registry

- Registry record: https://clinicaltrials.gov/study/NCT01924819
- Phase: PHASE2, PHASE3
- Status: ACTIVE_NOT_RECRUITING
- Sponsor: Australasian Gastro-Intestinal Trials Group
- Conditions: Gastric Cancer
- Interventions: Epirubicin + cisplatin + 5-fluorouracil OR epirubicin + cisplatin + capecitabine OR epirubicin + oxaliplatin + capecitabine OR 5-Fluorouracil + leucovorin + oxaliplatin + docetaxel; Preoperative chemoradiotherapy; Gastric resection
- Enrollment: 574
- Primary outcome: Overall survival

## Commentary we found

- X threads: 59
- Podcasts: 19
- YouTube: 15

## Order

Deep, $1,950, price fixed at order: https://www.erudio.com/contact?report=topgear-nct01924819

## Free build

POST https://www.erudio.com/api/trial-requests with {"nct_id": "NCT01924819", "email": "<work email>"}; the inbox owner confirms by the emailed link.